JOHNSON KENNETH ERLAND (See Remarks) reported 2 transactions at XERIS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/3/2025ACC: 0001867096-25-000023
Officer· See Remarks
Since Oct 2021
-41.32K
Net shares
Net seller
$147.1K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
41.32K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−15.48K
Price / share
$3.56
Trade value
$55.09K
% of position
4.3%
1/31/2025
361.76K→346.29K
Common Stock
Direct
Shares
−25.84K
Price / share
$3.56
Trade value
$92K
% of position
7.5%
1/31/2025
346.29K→320.45K
Total
Net shares
−41.32K
Net value
-$147.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −15.48K | $3.56 | $55.09K | 4.3% | 361.76K | 346.29K |
| Common Stock Direct | 1/31/2025 | F · Tax Withholding | −25.84K | $3.56 | $92K | 7.5% | 346.29K | 320.45K |
| Total | −41.32K | -$147.09K | ||||||
Derivative Transactions0
No derivative transactions reported